Figure 6. Color fundus photograph of an experimental eye showing hexadecyloxypropyl cytarabine 3’,5’-cyclic monophosphate (HDP-cP-Ara-C) drug depot at 16 weeks (A) and at 28 weeks (B) after the intravitreal injection of 800 μg of crystals. Panel B shows about 40% to 50% decrease of the drug depot over 12 weeks.